Boston Scientific Corp. v. Johnson and Johnson

Boston Scientific Corporation

Our patent litigators successfully concluded one of the fiercest battles in what courts and the media dubbed the “Stent Wars,” in cases where the damages sought approached or exceeded $1 billion.  Between 2007 and 2010, the Cordis division of Johnson & Johnson filed four separate cases accusing Boston Scientific’s multi-billion dollar Promus® stent of infringing patents on a variety of technologies.  Deploying a wide array of patent defenses, we obtained decisive victories in all four cases.

Email Disclaimer